Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic, B-Cell × Biopsy × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Lymphoma 12 Neoplasm Metastasis 9 Multiple Myeloma 9 Leukemia, Myeloid, Acute 8 Lung Neoplasms 7 Melanoma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Carcinoma, Non-Small-Cell Lung 5 Neuroblastoma 4 Lymphoma, Follicular 4 Burkitt Lymphoma 4 Sarcoma, Kaposi 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Malignant Solid Neoplasm 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 HIV Infections 3 Fallopian Tube Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2

Interventions

fludarabine phosphate 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 obinutuzumab 1 letermovir 1 carmustine, poliferprosan 20 drug combination 1 Tacrolimus 1 Stem Cell Transplantation 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Hematopoietic Stem Cell Transplantation 1 Etoposide 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Carmustine 1 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡